Home
>
US Stocks
>
R1 RCM Inc

R1 RCM Inc (RCM)

$16.81

+0.38

(+2.31%)▲

Market is closed - opens 7 PM, 05 Jun 2023

Insights on R1 RCM Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 924.7M → 545.6M (in $), with an average decrease of 41.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -57.5M → 300.0K (in $), with an average increase of 19266.7% per quarter

  • Vs VEEV

    In the last 1 year, Veeva Systems Inc - Class A has given 3.7% return, outperforming this stock by 26.4%

Performance

  • $16.50
    $16.83
    $16.81
    downward going graph

    1.87%

    Downside

    Day's Volatility :1.99%

    Upside

    0.12%

    downward going graph
  • $6.71
    $27.07
    $16.81
    downward going graph

    60.08%

    Downside

    52 Weeks Volatility :75.21%

    Upside

    37.9%

    downward going graph

Returns

PeriodR1 RCM IncSector (Health Care)Index (Russel 2000)
3 Months
14.74%
0.9%
-8.3%
6 Months
66.27%
-6.8%
-6.5%
1 Year
-22.68%
0.4%
-6.1%
3 Years
43.31%
27.3%
21.8%

Highlights

Market Capitalization
7.0B
Book Value
$6.5
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.27
PEG Ratio
0.77
Wall Street Target Price
19.56
Profit Margin
-4.41%
Operating Margin TTM
9.35%
Return On Assets TTM
3.53%
Return On Equity TTM
-5.62%
Revenue TTM
2.0B
Revenue Per Share TTM
5.08
Quarterly Revenue Growth YOY
41.5%
Gross Profit TTM
361.3M
EBITDA
403.0M
Diluted Eps TTM
-0.27
Quarterly Earnings Growth YOY
-0.99
EPS Estimate Current Year
0.04
EPS Estimate Next Year
0.23
EPS Estimate Current Quarter
-0.02
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    15%Hold
    0
    0%Sell
Based on 20 Wall street analysts offering stock ratings for R1 RCM Inc(by analysts ranked 0 to 5 stars)
Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
15
16
Hold
3
3
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 16.36%

Current $16.81
Target $19.56

Company Financials

FY17Y/Y Change
Revenue
449.8M
↓ 24.09%
Net Income
-58.8M
↓ 133.21%
Net Profit Margin
-13.07%
↓ 42.95%
FY18Y/Y Change
Revenue
868.5M
↑ 93.09%
Net Income
-45.3M
↓ 22.96%
Net Profit Margin
-5.22%
↑ 7.85%
FY19Y/Y Change
Revenue
1.2B
↑ 36.57%
Net Income
12.0M
↓ 126.49%
Net Profit Margin
1.01%
↑ 6.23%
FY20Y/Y Change
Revenue
1.3B
↑ 7.14%
Net Income
117.1M
↑ 875.83%
Net Profit Margin
9.21%
↑ 8.2%
FY21Y/Y Change
Revenue
1.5B
↑ 16.04%
Net Income
97.2M
↓ 16.99%
Net Profit Margin
6.59%
↓ 2.62%
FY22Y/Y Change
Revenue
1.8B
↑ 22.5%
Net Income
-57.6M
↓ 159.26%
Net Profit Margin
-3.19%
↓ 9.78%
Q4 FY21Q/Q Change
Revenue
398.9M
↑ 5.06%
Net Income
36.0M
↑ 111.76%
Net Profit Margin
9.02%
↑ 4.54%
Q1 FY22Q/Q Change
Revenue
385.7M
↓ 3.31%
Net Income
29.4M
↓ 18.33%
Net Profit Margin
7.62%
↓ 1.4%
Q2 FY22Q/Q Change
Revenue
391.9M
↑ 1.61%
Net Income
-20.4M
↓ 169.39%
Net Profit Margin
-5.21%
↓ 12.83%
Q3 FY22Q/Q Change
Revenue
496.0M
↑ 26.56%
Net Income
-29.5M
↑ 44.61%
Net Profit Margin
-5.95%
↓ 0.74%
Q4 FY22Q/Q Change
Revenue
924.7M
↑ 86.43%
Net Income
-57.5M
↑ 94.92%
Net Profit Margin
-6.22%
↓ 0.27%
Q1 FY23Q/Q Change
Revenue
545.6M
↓ 41.0%
Net Income
300.0K
↓ 100.52%
Net Profit Margin
0.05%
↑ 6.27%
FY17Y/Y Change
Total Assets
336.0M
↓ 19.05%
Total Liabilities
113.3M
↓ 55.71%
FY18Y/Y Change
Total Assets
807.5M
↑ 140.33%
Total Liabilities
801.2M
↑ 607.15%
FY19Y/Y Change
Total Assets
929.1M
↑ 15.06%
Total Liabilities
911.0M
↑ 13.7%
FY20Y/Y Change
Total Assets
1.2B
↑ 27.97%
Total Liabilities
1.1B
↑ 20.87%
FY21Y/Y Change
Total Assets
1.4B
↑ 21.89%
Total Liabilities
1.1B
↑ 0.14%
FY22Y/Y Change
Total Assets
5.1B
↑ 254.64%
Total Liabilities
2.4B
↑ 119.42%
Q4 FY21Q/Q Change
Total Assets
1.4B
↓ 2.3%
Total Liabilities
1.1B
↓ 4.06%
Q1 FY22Q/Q Change
Total Assets
1.4B
↓ 0.9%
Total Liabilities
1.1B
↓ 2.97%
Q2 FY22Q/Q Change
Total Assets
5.1B
↑ 254.4%
Total Liabilities
2.3B
↑ 118.7%
Q3 FY22Q/Q Change
Total Assets
5.1B
↓ 0.18%
Total Liabilities
2.3B
↓ 1.12%
Q4 FY22Q/Q Change
Total Assets
5.1B
↑ 1.16%
Total Liabilities
2.4B
↑ 4.58%
Q1 FY23Q/Q Change
Total Assets
5.1B
↓ 1.31%
Total Liabilities
2.4B
↓ 2.73%
FY17Y/Y Change
Operating Cash Flow
20.9M
↓ 124.06%
Investing Cash Flow
-33.6M
↑ 189.66%
Financing Cash Flow
-4.2M
↓ 102.38%
FY18Y/Y Change
Operating Cash Flow
18.3M
↓ 12.44%
Investing Cash Flow
-496.3M
↑ 1377.08%
Financing Cash Flow
377.4M
↓ 9085.71%
FY19Y/Y Change
Operating Cash Flow
113.9M
↑ 522.4%
Investing Cash Flow
-61.0M
↓ 87.71%
Financing Cash Flow
-25.3M
↓ 106.7%
FY20Y/Y Change
Operating Cash Flow
61.8M
↓ 45.74%
Investing Cash Flow
-117.0M
↑ 91.8%
Financing Cash Flow
137.9M
↓ 645.06%
FY21Y/Y Change
Operating Cash Flow
264.8M
↑ 328.48%
Investing Cash Flow
-340.4M
↑ 190.94%
Financing Cash Flow
31.4M
↓ 77.23%
Q4 FY21Q/Q Change
Operating Cash Flow
46.0M
↓ 49.06%
Investing Cash Flow
-14.9M
↓ 95.19%
Financing Cash Flow
-60.3M
↓ 128.28%
Q1 FY22Q/Q Change
Operating Cash Flow
30.9M
↓ 32.83%
Investing Cash Flow
-10.0M
↓ 32.89%
Financing Cash Flow
-26.2M
↓ 56.55%
Q2 FY22Q/Q Change
Operating Cash Flow
-96.4M
↓ 411.97%
Investing Cash Flow
-880.0M
↑ 8700.0%
Financing Cash Flow
1.0B
↓ 3984.35%
Q3 FY22Q/Q Change
Operating Cash Flow
26.0M
↓ 126.97%
Investing Cash Flow
-31.9M
↓ 96.37%
Financing Cash Flow
-26.0M
↓ 102.55%

Technicals Summary

Sell

Neutral

Buy

R1 RCM Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
R1 RCM Inc
R1 RCM Inc
8.17%
66.27%
-22.68%
43.31%
104.0%
Doximity, Inc.
Doximity, Inc.
-4.98%
-6.64%
-13.08%
-37.68%
-37.68%
Veeva Systems Inc.
Veeva Systems Inc.
9.53%
16.6%
3.74%
-9.4%
139.44%
GE HEALTHCARE TECHNOLOGIES INC.
GE HEALTHCARE TECHNOLOGIES INC.
0.33%
32.2%
32.2%
32.2%
32.2%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
R1 RCM Inc
R1 RCM Inc
128.18
NA
0.77
0.04
-0.06
0.04
0.0
6.5
Doximity, Inc.
Doximity, Inc.
60.05
60.05
NA
0.7
0.12
0.07
0.0
4.98
Veeva Systems Inc.
Veeva Systems Inc.
65.88
65.88
1.27
4.18
0.15
0.07
0.0
23.48
GE HEALTHCARE TECHNOLOGIES INC.
GE HEALTHCARE TECHNOLOGIES INC.
21.34
21.34
NA
3.73
0.16
0.06
0.0
14.72
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
R1 RCM Inc
R1 RCM Inc
Buy
$7.0B
104.0%
128.18
-4.41%
Doximity, Inc.
Doximity, Inc.
Buy
$6.4B
-37.68%
60.05
26.92%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$31.8B
139.44%
65.88
22.63%
GE HEALTHCARE TECHNOLOGIES INC.
GE HEALTHCARE TECHNOLOGIES INC.
Buy
$36.3B
32.2%
21.34
9.17%

Institutional Holdings

  • New Mountain Capital, L.L.C.

    22.57%

  • BlackRock Inc

    4.26%

  • Citadel Advisors Llc

    2.81%

  • Vanguard Group Inc

    2.73%

  • FMR Inc

    2.63%

  • Point72 Asset Management, L.P.

    2.59%

Company Information

R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.

Organization
R1 RCM Inc
Employees
27200
CEO
Mr. Joseph Gerard Flanagan
Industry
Health Services

Discover More

FAQs